Cargando…

HPLC–ICP-MS speciation analysis and risk assessment of arsenic in Cordyceps sinensis

BACKGROUND: Cordyceps sinensis, one of the most valued traditional herbal medicines in China, contains high amount of arsenic. Considering the adverse health effects of arsenic, this is of particular concern. The aim of this study was to determine and analyze arsenic speciation in C. sinensis, and t...

Descripción completa

Detalles Bibliográficos
Autores principales: Zuo, Tian-Tian, Li, Yao-Lei, Jin, Hong-Yu, Gao, Fei, Wang, Qi, Wang, Ya-Dan, Ma, Shuang-Cheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5902960/
https://www.ncbi.nlm.nih.gov/pubmed/29686726
http://dx.doi.org/10.1186/s13020-018-0178-9
_version_ 1783314852258775040
author Zuo, Tian-Tian
Li, Yao-Lei
Jin, Hong-Yu
Gao, Fei
Wang, Qi
Wang, Ya-Dan
Ma, Shuang-Cheng
author_facet Zuo, Tian-Tian
Li, Yao-Lei
Jin, Hong-Yu
Gao, Fei
Wang, Qi
Wang, Ya-Dan
Ma, Shuang-Cheng
author_sort Zuo, Tian-Tian
collection PubMed
description BACKGROUND: Cordyceps sinensis, one of the most valued traditional herbal medicines in China, contains high amount of arsenic. Considering the adverse health effects of arsenic, this is of particular concern. The aim of this study was to determine and analyze arsenic speciation in C. sinensis, and to measure the associated human health risks. METHODS: We used microwave extraction and high-performance liquid chromatography coupled with inductively coupled plasma mass spectrometry to determine and analyze the arsenic content in C. sinensis, and measured the associated human health risks according to the hazard index (HI), lifetime cancer risk (CR), and target hazard quotient (THQ). RESULTS: The main arsenic speciation in C. sinensis were not the four organic arsenic compounds, including dimethyl arsenic, monomethyl arsenic, arsenobetaine, and arsenocholine, but comprised inorganic arsenic and other unknown risk arsenic compounds. HI scores indicated that the risk of C. sinensis was acceptable. CR results suggested that the cancer risk was greater than the acceptable lifetime risk of 10(−5), even at low exposure levels. THQ results indicated that at the exposure level < 2.0 months/year, the arsenic was not likely to harm human health during a lifetime; however, if the exposure rate was > 3.0 months/year, the systemic effects of the arsenic in C. sinensis was of great concern. CONCLUSION: The arsenic in C. sinensis might not be free of risks. The suggested C. sinensis consumption rate of 2.0 months/year provided important insights into the ways by which to minimize potential health risks. Our study not only played the role of “cast a brick to attract jade” by which to analyze arsenic speciation in C. sinensis but also offered a promising strategy of risk assessment for harmful residues in traditional herbal medicines. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13020-018-0178-9) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5902960
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-59029602018-04-23 HPLC–ICP-MS speciation analysis and risk assessment of arsenic in Cordyceps sinensis Zuo, Tian-Tian Li, Yao-Lei Jin, Hong-Yu Gao, Fei Wang, Qi Wang, Ya-Dan Ma, Shuang-Cheng Chin Med Research BACKGROUND: Cordyceps sinensis, one of the most valued traditional herbal medicines in China, contains high amount of arsenic. Considering the adverse health effects of arsenic, this is of particular concern. The aim of this study was to determine and analyze arsenic speciation in C. sinensis, and to measure the associated human health risks. METHODS: We used microwave extraction and high-performance liquid chromatography coupled with inductively coupled plasma mass spectrometry to determine and analyze the arsenic content in C. sinensis, and measured the associated human health risks according to the hazard index (HI), lifetime cancer risk (CR), and target hazard quotient (THQ). RESULTS: The main arsenic speciation in C. sinensis were not the four organic arsenic compounds, including dimethyl arsenic, monomethyl arsenic, arsenobetaine, and arsenocholine, but comprised inorganic arsenic and other unknown risk arsenic compounds. HI scores indicated that the risk of C. sinensis was acceptable. CR results suggested that the cancer risk was greater than the acceptable lifetime risk of 10(−5), even at low exposure levels. THQ results indicated that at the exposure level < 2.0 months/year, the arsenic was not likely to harm human health during a lifetime; however, if the exposure rate was > 3.0 months/year, the systemic effects of the arsenic in C. sinensis was of great concern. CONCLUSION: The arsenic in C. sinensis might not be free of risks. The suggested C. sinensis consumption rate of 2.0 months/year provided important insights into the ways by which to minimize potential health risks. Our study not only played the role of “cast a brick to attract jade” by which to analyze arsenic speciation in C. sinensis but also offered a promising strategy of risk assessment for harmful residues in traditional herbal medicines. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13020-018-0178-9) contains supplementary material, which is available to authorized users. BioMed Central 2018-04-16 /pmc/articles/PMC5902960/ /pubmed/29686726 http://dx.doi.org/10.1186/s13020-018-0178-9 Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Zuo, Tian-Tian
Li, Yao-Lei
Jin, Hong-Yu
Gao, Fei
Wang, Qi
Wang, Ya-Dan
Ma, Shuang-Cheng
HPLC–ICP-MS speciation analysis and risk assessment of arsenic in Cordyceps sinensis
title HPLC–ICP-MS speciation analysis and risk assessment of arsenic in Cordyceps sinensis
title_full HPLC–ICP-MS speciation analysis and risk assessment of arsenic in Cordyceps sinensis
title_fullStr HPLC–ICP-MS speciation analysis and risk assessment of arsenic in Cordyceps sinensis
title_full_unstemmed HPLC–ICP-MS speciation analysis and risk assessment of arsenic in Cordyceps sinensis
title_short HPLC–ICP-MS speciation analysis and risk assessment of arsenic in Cordyceps sinensis
title_sort hplc–icp-ms speciation analysis and risk assessment of arsenic in cordyceps sinensis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5902960/
https://www.ncbi.nlm.nih.gov/pubmed/29686726
http://dx.doi.org/10.1186/s13020-018-0178-9
work_keys_str_mv AT zuotiantian hplcicpmsspeciationanalysisandriskassessmentofarsenicincordycepssinensis
AT liyaolei hplcicpmsspeciationanalysisandriskassessmentofarsenicincordycepssinensis
AT jinhongyu hplcicpmsspeciationanalysisandriskassessmentofarsenicincordycepssinensis
AT gaofei hplcicpmsspeciationanalysisandriskassessmentofarsenicincordycepssinensis
AT wangqi hplcicpmsspeciationanalysisandriskassessmentofarsenicincordycepssinensis
AT wangyadan hplcicpmsspeciationanalysisandriskassessmentofarsenicincordycepssinensis
AT mashuangcheng hplcicpmsspeciationanalysisandriskassessmentofarsenicincordycepssinensis